Between 29 March and 13 April 2016, the Office of the Inspector General published reports on three investigations – one each in India, Guyana and Bangladesh. The OIG identified non-compliant expenditures ranging from $56,966 for a malaria grant in Guyana to $311,637 for a TB grant in Bangladesh. This article provides a brief summary of the OIG’s findings.
In response to shortages of TB drugs experienced in 2014, and to risks that have been identified of additional shortages for drugs used for all three diseases, Kenya has put in place various measures to reduce the risk of treatment disruptions.
The Office of the Inspector General has awarded the Global Fund Secretariat generally high marks with respect to compliance with key internal policies, particularly operational and financial controls. The OIG released a report on an audit into these functions on 4 March 2016.
In January, in response to a shortage of antiretrovirals in Uganda, The Global Fund Secretariat arranged to procure a supply of the drugs. In addition, as a precautionary measure, the Secretariat is providing Uganda with a full year’s supply of drugs, the first batch of which is expected to arrive in March. This comes as a relief to the 241,000 Ugandans who are receiving ARVs purchased with money from The Global Fund.
As a result of a new tender for insecticide-treated mosquito nets, The Global Fund projects that it will achieve savings of $93 million over the next two years. The Global Fund expects to make $350 million in mosquito net purchases in that time period through its pooled procurement mechanism.
The Global Fund’s new market-shaping strategy is designed to allow the Fund to play a more active role in shaping market dynamics to increase access to health products. The new strategy, which was adopted by the Board at its meeting on 16-17 November, includes a section on preparing for when countries transition away from Fund support.
OIG investigations in 2015 show that misuse of funds occurs most often in procurement, construction and training
According to the Office of the Inspector General, the main source of misconduct identified this year through its investigations has been activities related to procurement. “Non-competitive tenders, fictitious invoicing and collusion between suppliers and procurement or finance managers have frequently led to fraud,” the OIG said.
This information was contained in the semi-annual progress report prepared by the OIG for the Board.
Although significant progress was made since the last Board meeting on implementing agreed management actions, the total number of overdue AMAs and the proportion of overdue AMAs have both increased.
This information was contained in a paper prepared by the Office of the Inspector General for the Board meeting on 16-17 November. The paper included a response from the Secretariat.
Emails released by the U.S. State Department contradict statements by the Fund concerning the resignation of Michel Kazatchkine in 2012
An investigation by the Office of the Inspector General has found evidence of non-competitive tenders and other improper procurement practices by a sub-recipient of an HIV grant to Timor-Leste totaling $152,626, a portion of which the OIG attributed to fraud, overpricing and non-delivery of items. A report on the investigation was released on 9 October.